Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer’s disease

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.2, 1999-02, pp. : 201-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana   Castro Ana  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Transgenic animal model for Alzheimer’s disease

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite

Clinically tested drugs for Alzheimer’s disease

By McGeer Edith G   McGeer Patrick L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1143-1151

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory drugs: a hope for Alzheimer’s disease?

By Hüll M.   Lieb K.   Fiebich B.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 671-683

Informa Healthcare

Access to resources Recommend Favorite